Bank of America’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$548K Buy
324,133
+212,430
+190% +$377K ﹤0.01% 4844
2025
Q4
$159K Buy
111,703
+35,900
+47% +$52.3K ﹤0.01% 5447
2025
Q3
$124K Sell
75,803
-6,744
-8% -$7.5K ﹤0.01% 6504
2025
Q2
$60.3K Sell
82,547
-23,768
-22% -$20.5K ﹤0.01% 6738
2025
Q1
$85.8K Sell
106,315
-47,017
-31% -$54.1K ﹤0.01% 6559
2024
Q4
$212K Sell
153,332
-508,348
-77% -$570K ﹤0.01% 6088
2024
Q3
$688K Buy
661,680
+386,585
+141% +$530K ﹤0.01% 5290
2024
Q2
$476K Sell
275,095
-2,152,130
-89% -$4.33M ﹤0.01% 5374
2024
Q1
$5.8M Buy
2,427,225
+308,421
+15% +$759K ﹤0.01% 3471
2023
Q4
$7.06M Buy
2,118,804
+645,221
+44% +$1.73M ﹤0.01% 3245
2023
Q3
$5.51M Buy
1,473,583
+1,304,408
+771% +$6.02M ﹤0.01% 3317
2023
Q2
$722K Sell
169,175
-398,199
-70% -$2.35M ﹤0.01% 5003
2023
Q1
$3.88M Buy
567,374
+184,924
+48% +$1.44M ﹤0.01% 3758
2022
Q4
$3.03M Buy
382,450
+111,370
+41% +$857K ﹤0.01% 3880
2022
Q3
$2.6M Buy
271,080
+58,442
+27% +$591K ﹤0.01% 4041
2022
Q2
$1.54M Sell
212,638
-33,955
-14% -$295K ﹤0.01% 4528
2022
Q1
$3.18M Buy
246,593
+40,380
+20% +$513K ﹤0.01% 4107
2021
Q4
$3.29M Sell
206,213
-56,534
-22% -$989K ﹤0.01% 4060
2021
Q3
$4.22M Buy
262,747
+10,760
+4% +$158K ﹤0.01% 3726
2021
Q2
$3.48M Buy
251,987
+104,463
+71% +$1.48M ﹤0.01% 3852
2021
Q1
$2.15M Buy
147,524
+3,581
+2% +$60.8K ﹤0.01% 4197
2020
Q4
$2.5M Buy
143,943
+68,230
+90% +$1.21M ﹤0.01% 3749
2020
Q3
$1.39M Sell
75,713
-6,747
-8% -$126K ﹤0.01% 3952
2020
Q2
$1.47M Sell
82,460
-7,532
-8% -$127K ﹤0.01% 3838
2020
Q1
$1.46M Buy
89,992
+47,679
+113% +$881K ﹤0.01% 3734
2019
Q4
$762K Sell
42,313
-17,392
-29% -$321K ﹤0.01% 4688
2019
Q3
$1.21M Sell
59,705
-44,392
-43% -$887K ﹤0.01% 4417
2019
Q2
$2.3M Sell
104,097
-111,052
-52% -$1.93M ﹤0.01% 3933
2019
Q1
$2.94M Buy
215,149
+88,824
+70% +$1.19M ﹤0.01% 3667
2018
Q4
$1.14M Buy
126,325
+75,928
+151% +$879K ﹤0.01% 4299
2018
Q3
$832K Sell
50,397
-12,543
-20% -$222K ﹤0.01% 4604
2018
Q2
$882K Sell
62,940
-5,244
-8% -$75.1K ﹤0.01% 4552
2018
Q1
$754K Buy
68,184
+43,155
+172% +$472K ﹤0.01% 4569
2017
Q4
$220K Sell
25,029
-3,597
-13% -$38.5K ﹤0.01% 5356
2017
Q3
$383K Sell
28,626
-36,654
-56% -$485K ﹤0.01% 5103
2017
Q2
$937K Buy
65,280
+46,972
+257% +$903K ﹤0.01% 4475
2017
Q1
$387K Buy
18,308
+11,553
+171% +$284K ﹤0.01% 5027
2016
Q4
$190K Sell
6,755
-32,754
-83% -$917K ﹤0.01% 5348
2016
Q3
$1.06M Buy
39,509
+34,612
+707% +$944K ﹤0.01% 4117
2016
Q2
$83K Buy
4,897
+3,357
+218% +$63K ﹤0.01% 5611
2016
Q1
$33K Sell
1,540
-6,274
-80% -$103K ﹤0.01% 5936
2015
Q4
$179K Buy
7,814
+6,690
+595% +$172K ﹤0.01% 5442
2015
Q3
$23K Sell
1,124
-577
-34% -$17.6K ﹤0.01% 6260
2015
Q2
$49K Buy
1,701
+1,683
+9,350% +$42.5K ﹤0.01% 5948
2015
Q1
$1K Buy
+18
New +$465 ﹤0.01% 6784

Other funds holding CHRS